Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;30(7):564-573.
doi: 10.1038/s41422-020-0350-5. Epub 2020 Jun 3.

Cryo-EM structures of inactive and active GABAB receptor

Affiliations

Cryo-EM structures of inactive and active GABAB receptor

Chunyou Mao et al. Cell Res. 2020 Jul.

Abstract

Metabotropic GABAB G protein-coupled receptor functions as a mandatory heterodimer of GB1 and GB2 subunits and mediates inhibitory neurotransmission in the central nervous system. Each subunit is composed of the extracellular Venus flytrap (VFT) domain and transmembrane (TM) domain. Here we present cryo-EM structures of full-length human heterodimeric GABAB receptor in the antagonist-bound inactive state and in the active state complexed with an agonist and a positive allosteric modulator in the presence of Gi1 protein at a resolution range of 2.8-3.0 Å. Our structures reveal that agonist binding stabilizes the closure of GB1 VFT, which in turn triggers a rearrangement of TM interfaces between the two subunits from TM3-TM5/TM3-TM5 in the inactive state to TM6/TM6 in the active state and finally induces the opening of intracellular loop 3 and synergistic shifting of TM3, 4 and 5 helices in GB2 TM domain to accommodate the α5-helix of Gi1. We also observed that the positive allosteric modulator anchors at the dimeric interface of TM domains. These results provide a structural framework for understanding class C GPCR activation and a rational template for allosteric modulator design targeting the dimeric interface of GABAB receptor.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Cryo-EM structures of GABAB receptor in the inactive and active states.
a, b Cryo-EM density maps (left), models (middle) and maps colored according to local resolution (right) for the GABAB receptor in the presence of CGP54626 (slate; antagonist) (a) and in complex with baclofen (magenta; agonist), BHFF (steel blue; PAM) and Gi1 protein (b). The colored density map is a composite map generated with the VFT and TMD locally refined map. The cryo-EM density map before focused refinement in transparent superposed with the final map, illustrating density for detergent micelle and Gi1 protein. The local resolution (Å) was calculated with the locally refined map as input, indicating a range of 2.5–3.5 Å resolution in most map regions for both the inactive and active states. GB1 and GB2 in inactive state, blue and yellow, respectively; red and green in active state, respectively.
Fig. 2
Fig. 2. Structural comparison of GABAB receptor in inactive and active states.
a, b Orthogonal views of the superimposed structures of GABAB receptor in inactive and active states, showing the domain repositioning upon agonist binding-induced activation. Side views (a) and intracellular views (b) of superposed structures are shown, with the active structure in translucent in the left panels and the inactive structure in translucent in the right panels, respectively. VFT domains and loops are omitted for clarity in b. Red arrows indicate the translation direction and distance for GB1 and GB2 (measured at extracellular tips of TM1 helices), respectively. Structures were aligned on the combined domains of GB1 VFT and GB2 lobe 1, the relatively stable parts of the receptor along activation pathway.
Fig. 3
Fig. 3. Structural details of the TM heterodimeric interfaces for the inactive and active GABAB structures.
a, b Side (a) and intracellular (b) views of the inactive TM interface. EM densities (magenta) corresponding to putative cholesterols are shown in surface. c Close view of inactive TM interface proximal to the cytoplasm. H6893.55 and E7905.60 of GB1, H5793.55 and E6775.60 of GB2 forms salt bridge network to stabilize an inactive conformation. d Detailed interactions of the TM interface in the active state. e, f Cryo-EM density (e) and the detailed interactions (f) of (+)-BHFF (PAM) in the active TM interface. The critical residues are shown as sticks. Hydrogen bonds are depicted as dashed lines.
Fig. 4
Fig. 4. Structural comparison of individual TM domains between inactive and active states.
a, b GB1 TM domain (a) and GB2 TM domain (b) between inactive and active states are superposed, respectively. Side, extracellular and intracellular views are shown. Magnified views of the stalk domains are shown in the left. Red arrows represent the movement direction and distance of TMs and loops.
Fig. 5
Fig. 5. Three distinct modes of Gi1 coupling to GABAB receptor.
a–c Cryo-EM density maps and the models of the GABAB–Gi1 complex in B2a state (a), B2b state (b), and B1 state (c). GB1 in red, GB2 in green, Gαi in gold, Gβ in cyan, Gγ in purple and scFv16 in gray. d Magnified view of the interaction between the α5-helix of the Gαi and GABAB receptor in B2a state is shown. Intracellular loops 1, 2, and 3 are highlighted. e Superposition of the B1 state with either B2a state or B2b state showing the potential steric clash between Gi proteins, indicating that only one Gi protein can bind to GABAB receptor at one time. Gi in B2a state, brown; Gi in B2b state, blue; Gi in B1 state, gray.

Comment in

Similar articles

  • Structural Basis for Activation of the Heterodimeric GABAB Receptor.
    Kim Y, Jeong E, Jeong JH, Kim Y, Cho Y. Kim Y, et al. J Mol Biol. 2020 Nov 6;432(22):5966-5984. doi: 10.1016/j.jmb.2020.09.023. Epub 2020 Oct 12. J Mol Biol. 2020. PMID: 33058878
  • Structural basis of the activation of a metabotropic GABA receptor.
    Shaye H, Ishchenko A, Lam JH, Han GW, Xue L, Rondard P, Pin JP, Katritch V, Gati C, Cherezov V. Shaye H, et al. Nature. 2020 Aug;584(7820):298-303. doi: 10.1038/s41586-020-2408-4. Epub 2020 Jun 17. Nature. 2020. PMID: 32555460 Free PMC article.
  • Structure of human GABAB receptor in an inactive state.
    Park J, Fu Z, Frangaj A, Liu J, Mosyak L, Shen T, Slavkovich VN, Ray KM, Taura J, Cao B, Geng Y, Zuo H, Kou Y, Grassucci R, Chen S, Liu Z, Lin X, Williams JP, Rice WJ, Eng ET, Huang RK, Soni RK, Kloss B, Yu Z, Javitch JA, Hendrickson WA, Slesinger PA, Quick M, Graziano J, Yu H, Fiehn O, Clarke OB, Frank J, Fan QR. Park J, et al. Nature. 2020 Aug;584(7820):304-309. doi: 10.1038/s41586-020-2452-0. Epub 2020 Jun 24. Nature. 2020. PMID: 32581365 Free PMC article.
  • Structural biology of GABAB receptor.
    Frangaj A, Fan QR. Frangaj A, et al. Neuropharmacology. 2018 Jul 1;136(Pt A):68-79. doi: 10.1016/j.neuropharm.2017.10.011. Epub 2017 Oct 12. Neuropharmacology. 2018. PMID: 29031577 Free PMC article. Review.
  • The GABAB Receptor-Structure, Ligand Binding and Drug Development.
    Evenseth LSM, Gabrielsen M, Sylte I. Evenseth LSM, et al. Molecules. 2020 Jul 7;25(13):3093. doi: 10.3390/molecules25133093. Molecules. 2020. PMID: 32646032 Free PMC article. Review.

Cited by

References

    1. Barnard EA, et al. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 1998;50:291–313. - PubMed
    1. Bettler B, Tiao JY. Molecular diversity, trafficking and subcellular localization of GABAB receptors. Pharmacol. Ther. 2006;110:533–543. - PubMed
    1. Kaupmann K, et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature. 1998;396:683–687. - PubMed
    1. Mott DD, Lewis DV. The pharmacology and function of central GABAB receptors. Int. Rev. Neurobiol. 1994;36:97–223. - PubMed
    1. Bettler B, Kaupmann K, Mosbacher J, Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol. Rev. 2004;84:835–867. - PubMed

Publication types

MeSH terms

Substances